Showing results (641-650 of 698) with videos related to

Sort By:
Pageof 70
Bioorganic & Medicinal Chemistry Letters|June 13, 2022
Optimization of clofibrate with O-desmethyl anetholtrithione lead to a novel hypolipidemia compound with hepatoprotective effectHaitao Liu, Panpan Zhang, Xiaoxiao Ge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Mild kidney dysfunction affects the predictive accuracy of blood-based biomarkers for neuropsychological and neuroimaging outcomes over a 9 year follow-up periodCorey J Bolton, Panpan Zhang, Devika Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.
BMC Cancer|April 14, 2025
Immune checkpoint inhibitor-related myocarditis in patients with lung cancerWenli Cao, Sen Han, Panpan Zhang, et al.
Rheumatology (Oxford, England)|December 20, 2020
UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related diseaseYiyi Gong, Panpan Zhang, Zheng Liu, et al.
Nano Letters|November 9, 2019
Observation of the Kondo Effect in Multilayer Single-Crystalline VTe2 NanoplatesHongtao Liu, Yunzhou Xue, Jin-An Shi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 28, 2025
Increased neuroplastic activity in the pathogenesis of Alzheimer's diseaseCorey J Bolton, Panpan Zhang, Sydney R Wilhoite, et al.
Nature Communications|April 10, 2025
Super-saturated complementary carbon nanotube transistors with intrinsic gain singularitiesGuanhua Long, Yuru Wang, Tianshun Bai, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The Dynamics of Cognitive Decline towards Alzheimer's Disease Progression: Results from ADSP-PHC's Harmonized Cognitive CompositesKaidi Kang, Panpan Zhang, Logan Dumitrescu, et al.
The Oncologist|December 10, 2020
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, et al.
Pageof 70